Abbott stock gains 3.17% as price holds above key short- and medium-term averages

Traders Union
All News
Financial News
Abbott gains 3.17% to $90.62 today

Highlights

ABT/USD displays short- and medium-term bullish momentum but remains challenged by longer-term selling pressure.
Momentum indicators are mixed, with price action and volume bullish while oscillators signal overbought short-term conditions.
Expect ABT/USD to trade between $88.67 and $92.57, with 75% probability of a continued upward bias.

Bullish price action contrasts with overbought technical signals

On the hourly chart, ABT is positioned above the MA-20 at $88.63 and the MA-50 at $88.89, with immediate support defined by the Ichimoku Kijun at $89.4. The daily MA-200, serving as longer-term resistance, stands at $113.42. Momentum readings are mixed: RSI has climbed to 62.66, indicating bullish bias, while Stoch RSI and CCI are both registering overbought conditions. The Bull/Bear Power (BBP) signals continued buyer dominance. MACD and ADX remain neutral, whereas the Awesome Oscillator is firmly in buy territory, confirming the prevailing move higher. These divergences between strong price and oscillator overbought conditions suggest that short-term bullish sentiment may be stretched.

Upside bias sustained as key support and resistance shape outlook

Looking ahead, ABT is likely to trade sideways to higher within a typical volatility band between $88.67 and $92.57 over the coming days. The uptrend probability is estimated at 75%, favoring continued bullish momentum, while a dip below $88.67 support holds a 25% chance. A break above $92.57 would open the door to further gains, whereas a move below $88.67 may trigger additional selling pressure.

Viktoras Karapetjanc, expert at Traders Union, sees strong near-term momentum in Abbott Laboratories, supported by its position above key moving averages and solid buyer sentiment. He notes that technical oscillators show bullish bias but warn of possible short-term overheating. No notable news catalysts have emerged. Karapetjanc believes the price is set to consolidate or extend higher within the $88.67 to $92.57 range. "With positive momentum intact and sentiment leaning bullish, I see a 75% chance for ABT to continue its upward move, provided it holds above key support."

Earlier, analysts noted that Abbott Laboratories was locked in a sustained bearish trend, with technical signals pointing to continued downside risk. The recent shift to bullish momentum now presents a potential trend reversal, making a close above the $92.57 resistance level a critical indicator for further near-term gains.

Source of Data: ABT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.